Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
130.1 USD | +0.35% | +2.13% | +4.84% |
Apr. 30 | Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology | CI |
Apr. 26 | Wall Street: the worst week of 2024 is followed by the best | CF |
Financials (USD)
Sales 2024 * | 4.33B | Sales 2025 * | 5.15B | Capitalization | 51.56B |
---|---|---|---|---|---|
Net income 2024 * | 716M | Net income 2025 * | 898M | EV / Sales 2024 * | 12.2 x |
Net Debt 2024 * | 1.43B | Net Debt 2025 * | 1.02B | EV / Sales 2025 * | 10.2 x |
P/E ratio 2024 * |
73.8
x | P/E ratio 2025 * |
60.1
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.63% |
Latest transcript on DexCom, Inc.
1 day | +0.35% | ||
1 week | +2.13% | ||
Current month | +2.13% | ||
1 month | -7.03% | ||
3 months | +2.76% | ||
6 months | +36.67% | ||
Current year | +4.84% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 07-10-31 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 18-08-31 |
Chief Tech/Sci/R&D Officer | 47 | 22-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 09-11-19 |
Mark Foletta
BRD | Director/Board Member | 63 | 14-11-18 |
Eric Topol
BRD | Director/Board Member | 69 | 09-07-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.46% | 0 M€ | +5.44% | - | |
1.04% | 0 M€ | -3.93% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 130.1 | +0.35% | 1,425,158 |
24-05-06 | 129.6 | +1.00% | 1,858,416 |
24-05-03 | 128.4 | +1.36% | 1,778,982 |
24-05-02 | 126.6 | +0.61% | 2,311,410 |
24-05-01 | 125.9 | -1.19% | 2,916,511 |
Delayed Quote Nasdaq, May 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.84% | 51.56B | |
-3.54% | 184B | |
-0.58% | 109B | |
-2.74% | 68.37B | |
+10.40% | 44.69B | |
+4.37% | 41.49B | |
+2.87% | 26.75B | |
+4.61% | 26.7B | |
+15.38% | 25.68B | |
-0.22% | 24.8B |
- Stock Market
- Equities
- DXCM Stock